$IBM Options Intelligence

🎯 SELL IBM FEB 20 295/290 PUT SPREAD

I recommend this credit spread because the term structure reveals a compelling premium-selling opportunity: the 7-day Clean IV at 28.2% sits significantly below the 40.1% baseline volatility, creating an underpriced near-term window. However, the 2-day expiration at 37.1% is overpriced relative to baseline, making Feb 20 the optimal sweet spot for selling premium. Combined with IBM's neutral RSI (45.63), price trading 1.9% below the 20-day MA ($297.81), and strong analyst upgrades (Evercore raised target to $345, Bank of America to $335), this spread captures mean reversion while the stock consolidates before the new FlashSystem launch on March 6.[1][2][3][4]

Sell IBM Feb 20 295/290 Put Spread
Stock Price: $291.73 | Entry: $0.95 credit

📊 Trade Metrics

• Risk: $405 | Reward: $95 (23% return)
• Breakeven: $294.05
• Max Loss: $405 if IBM < $290 at expiry
• Max Profit: $95 if IBM > $295 at expiry
• Win Rate: 68% (based on delta)
• Days to Expiration: 9

📈 Term Structure & Volatility Analysis

• Baseline 90-day Vol: 30.9%
• 7-day Clean IV: 28.2% (2.7% below baseline = UNDERPRICED)
• 2-day Clean IV: 37.1% (6.2% above baseline = OVERPRICED)
• Market IV: 40.1% (elevated vs historical 7.3%)
• IV Rank: 100% (extreme high - premium selling favored)
• Calendar Opportunity: Yes - 2d vs 7d shows 8.9% IV differential
• Recommendation: Sell near-term premium (Feb 20) rather than 2-day overpriced expiry

📈 Greeks & Volatility

• Net Delta: +0.32 (bullish bias)
• Theta: $12/day (strong time decay benefit)
• Vega: +$6 (benefits from IV contraction)
• Current IV: 40.1% (vs 7.3% historical = 5.5x elevated)
• Put/Call Ratio: 0.40 (very bullish - 2.5 calls for every 1 put)
• Expected Daily Move: ±$7.38 (2.53%)

🎯 Why This Trade

The term structure analysis is decisive: Feb 20 expiration offers 28.2% Clean IV—below the 30.9% baseline—making options underpriced *relative to historical norms*, yet the market's 40.1% absolute IV is still elevated. This creates a rare confluence: sell premium while it's still expensive in absolute terms, but before it collapses further. IBM's technical setup supports this: RSI at 45.63 is perfectly neutral (not overbought), price sits 1.9% *below* the 20-day MA, suggesting the recent -1.56% decline has created a mild oversold condition ripe for mean reversion.[1] Analyst sentiment is strongly bullish—Evercore raised targets to $345, Bank of America to $335, and Wedbush to $340—all implying 15-18% upside from current levels.[2][3] The new FlashSystem portfolio with agentic AI launches March 6, providing a near-term catalyst.[4] This put spread captures the bounce while limiting downside risk to $405 (only 0.14% of IBM's market cap). The 9-day timeframe is ideal: enough time for theta decay to work (collecting $12/day), but short enough to avoid earnings (April 22) and the FlashSystem launch event.

📊 Pro Analysis

• Current IV: 40.1% vs Historical: 7.3% (5.5x elevated)
• IV Rank: 100% (maximum - sell premium strategies strongly favored)
• Expected Daily Move: ±$7.38 (2.53%)
• Put/Call Ratio: 0.40 (very bullish sentiment)
• Market Maker Max Pain: $330 (supports upside bias)
• Technical: RSI 45.63 (neutral), Price 1.9% below 20MA, Support at $284.13 (200MA)
• Institutional Activity: ING Groep NV increased position 12.11%, while Advisors Asset Management sold (mixed signals, but net institutional accumulation)[2]

💡 Trade Management

• Entry: Sell to open at $0.95 credit (mid of bid/ask)
• Target: Buy to close at $0.50 (47% profit, 4 days before expiry)
• Stop: Exit if IBM closes above $296 (threatened short strike)
• Time Stop: Close 2 days before expiration (Feb 18) to avoid gamma risk

📅 Earnings Date Check

Earnings on April 22 (70 days away). ✅ Validation: Feb 20 expiry is 61 days BEFORE earnings—this is a SHORT-TERM income trade, NOT an earnings play. The position will close well before earnings volatility expansion.

🔍 Market Overview

IBM trades at a forward P/E of 23.7x, now exceeding Microsoft's 23.0x for the first time in a decade, reflecting renewed investor confidence in IBM's AI positioning.[4] The stock's 2.30% dividend yield ($6.72 annualized) provides downside cushion; next ex-date is Feb 10 (already passed). Technical support sits at the 200-day MA of $279.99, providing a $12 buffer below the short strike. IBM's beta of 0.69 indicates lower volatility than the broader market, supporting a credit spread strategy. Sector peers (MSFT, GOOGL, ORCL, NVDA) are mixed, but IBM's enterprise software/services focus offers stability. The Feb 20 expiration avoids the Non-Farm Payrolls (March 6) and CPI (March 11) events, reducing